what's trending

5 most popular innovation stories in Houston this week

InnovationMap announces its big winners, innovators to know this week, and more local innovation news trended this week. Photo via Getty Images

Editor's note:Another week has come and gone, and it's time to round up the top headlines from the past few days. Trending Houston tech and startup news on InnovationMap overwhelmingly included coverage of the inaigural InnovationMap Awards presented by Techwave, which took place this week, innovators to know, and a guest post.

3 Houston innovators to know this week

This week's roundup of Houston innovators includes former city council member Amanda Edwards, Gaurav Khandelwal of Velostics, and Anshumali Shrivastava of ThirdAI. Courtesy photos

In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from logistics tech to computer science — recently making headlines in Houston innovation. Click here to continue reading.

InnovationMap reveals the winners of our inaugural awards

The inaugural InnovationMap Awards revealed its big winners across eight categories and honored its Trailblazer Award recipient. Photos courtesy

The votes are in — and it's time to announce the winners of the inaugural InnovationMap Awards, presented by Techwave.

The event, held September 8 at The Cannon, honored all 28 finalists, spanning innovative Houston companies and founders, as well as our first-ever Trailblazer Award recipient, Barbara Burger. Click here to read about all the finalists.

Eight judges evaluated over 100 applications across eight categories for the 2021 InnovationMap Awards presented by Techwave. This year's judges included: JulianaGaraizar, head of the Houston incubator and vice president of innovation at Greentown Labs; Alex Gras, managing director at The Cannon; Rajasekhar Gummadapu, co-founder and CEO of Techwave; Natalie Harms, editor of InnovationMap; Serafina Lalany, interim president at Houston Exponential; Jon Nordby, managing director at MassChallenge; Emily Reiser, senior manager of innovation community engagement at the Texas Medical Center; and Grace Rodriguez, CEO and executive director of Impact Hub Houston.

Without further adieu, here are our 2021 InnovationMap Award winners. Click here to continue reading.

Overheard: Young founders explain the challenges they've faced

The five finalists in the Top Founder Under 40 category for the inaugural InnovationMap Awards share the challenges they have had to overcome. Photos courtesy

It's not easy being the youngest person in a room, and that's certainly the case for startup founders looking to make an impact on an industry that's been doing things a certain way since before they were born.

The five finalists of the Top Founder Under 40 category for the InnovationMap Awards presented by Techwave were asked to share their challenges overcame as young founders. Here's what they had to say. Click here to continue reading.

Houston founders share the challenges they've had to overcome as women in tech

The five finalists in the Female-Founded Business category for the inaugural InnovationMap Awards share the challenges they overcame as female founders. Photos courtesy

Even in 2021, women face discrimination in the workplace — whether it's running their own businesses or climbing the corporate ladder.

The five female finalists of the Female-Founded Business category for the InnovationMap Awards presented by Techwave were asked to share their challenges overcame as female founders. Here's what they had to say. Click here to continue reading.

Houston research: Understanding the limit to our professional networks

Robin Dunbar, an anthropologist from England, has been studying and refining his theory on how large human networks can realistically get. Graphic byMiguel Tovar/University of Houston

You go to conferences; you network; you collaborate — all researchers and academics do. But do you need more than 150 contacts? Linkedin, Facebook, Twitter — all of these platforms open us up to the possibility of thousands of acquaintances, though fewer we would refer to as "friends." Click here to continue reading.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted